Mediclin Stock

Mediclin Revenue

The The revenue of Mediclin (MED.DE) as of Mar 12, 2026 is 809.62 M EUR. In the previous year, The revenue was 790.22 M EUR — a change of 2.46% (higher).

Revenue

809.62 MEUR

YoY

2.46%

Last updated: Mar 12, 2026

In 2026, Mediclin's sales reached 809.62 M EUR, a 2.46% difference from the 790.22 M EUR sales recorded in the previous year.

The Mediclin Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

REVENUE (M EUR)
GROSS MARGIN (%)
Date
REVENUE (M EUR)
GROSS MARGIN (%)
Jan 1, 2005
377.9 base
7,986 base
Jan 1, 2006
387.4 base
7,927 base
Jan 1, 2007
398.2 base
7,880 base
Jan 1, 2008
466.1 base
7,737 base
Jan 1, 2009
480.1 base
7,761 base
Jan 1, 2010
497.4 base
7,780 base
Jan 1, 2011
505.9 base
7,818 base
Jan 1, 2012
517.6 base
7,854 base
Jan 1, 2013
521.9 base
7,873 base
Jan 1, 2014
544.97 base
8,038 base
Jan 1, 2015
562.08 base
8,166 base
Jan 1, 2016
589.45 base
8,156 base
Jan 1, 2017
626.41 base
8,202 base
Jan 1, 2018
654.95 base
8,177 base
Jan 1, 2019
686.44 base
8,238 base
YEARREVENUE (M EUR)GROSS MARGIN (%)
2027 est 825.8877,01
2026 est 809.6278,56
2025 est 790.2280,49
2024 765.0883,13
2023 766.7582,08
2022 722.3281,62
2021 687.0882,22
2020 670.9983,21
2019 686.4482,38
2018 654.9581,77
2017 626.4182,02
2016 589.4581,56
2015 562.0881,66
2014 544.9780,38
2013 521.978,73
2012 517.678,54
2011 505.978,18
2010 497.477,80
2009 480.177,61
2008 466.177,37
2007 398.278,80
2006 387.479,27
2005 377.979,86
API Docs Get API Key

Mediclin Revenue

Mediclin Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2005
377.9 M EUR
16.1 M EUR
7.7 M EUR
Jan 1, 2006
387.4 M EUR
16.7 M EUR
9.5 M EUR
Jan 1, 2007
398.2 M EUR
18.9 M EUR
5.7 M EUR
Jan 1, 2008
466.1 M EUR
15.8 M EUR
7.1 M EUR
Jan 1, 2009
480.1 M EUR
17 M EUR
10.3 M EUR
Jan 1, 2010
497.4 M EUR
16.9 M EUR
10 M EUR
Jan 1, 2011
505.9 M EUR
10.9 M EUR
3 M EUR
Jan 1, 2012
517.6 M EUR
5.1 M EUR
-1.4 M EUR
Jan 1, 2013
521.9 M EUR
2.1 M EUR
-2.6 M EUR
Jan 1, 2014
544.97 M EUR
15.56 M EUR
8.5 M EUR
Jan 1, 2015
562.08 M EUR
23.61 M EUR
16.54 M EUR
Jan 1, 2016
589.45 M EUR
24.02 M EUR
16.55 M EUR
Jan 1, 2017
626.41 M EUR
6.62 M EUR
3.91 M EUR
Jan 1, 2018
654.95 M EUR
15.06 M EUR
7.72 M EUR
Jan 1, 2019
686.44 M EUR
22.41 M EUR
9.66 M EUR

Mediclin Margins

Mediclin stock margins

The Mediclin margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Mediclin. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Mediclin.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2005
79.86 %
4.26 %
2.04 %
Jan 1, 2006
79.27 %
4.31 %
2.45 %
Jan 1, 2007
78.8 %
4.75 %
1.43 %
Jan 1, 2008
77.37 %
3.39 %
1.52 %
Jan 1, 2009
77.61 %
3.54 %
2.15 %
Jan 1, 2010
77.8 %
3.4 %
2.01 %
Jan 1, 2011
78.18 %
2.15 %
0.59 %
Jan 1, 2012
78.54 %
0.99 %
-0.27 %
Jan 1, 2013
78.73 %
0.4 %
-0.5 %
Jan 1, 2014
80.38 %
2.86 %
1.56 %
Jan 1, 2015
81.66 %
4.2 %
2.94 %
Jan 1, 2016
81.56 %
4.08 %
2.81 %
Jan 1, 2017
82.02 %
1.06 %
0.62 %
Jan 1, 2018
81.77 %
2.3 %
1.18 %
Jan 1, 2019
82.38 %
3.27 %
1.41 %

Mediclin Stock analysis

What does Mediclin do? Mediclin AG is a German company specializing in the care and treatment of patients. It was founded in 1984 in Berlin and has since relocated its headquarters to Offenburg. Mediclin operates over 50 healthcare facilities throughout Germany, including hospitals, rehabilitation centers, nursing facilities, and medical care centers. The company employs approximately 10,000 employees and generated a revenue of 1.17 billion euros in 2020. Mediclin is one of the most popular companies on Eulerpool.com.

Revenue Details

Understanding Mediclin's Sales Figures

The sales figures of Mediclin originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Mediclin’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Mediclin's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Mediclin’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Mediclin stock

The revenue of Mediclin amounted to 790.22 M EUR 809.62 M

The revenue in assessing a stock

Revenue is an important financial measure used in the valuation of stocks. It is a measure of a company's economic activity and can serve as an indicator of the company's success. Revenue is considered one of the most important factors in stock valuation. In addition, revenue can also be used to calculate other financial measures such as earnings per share and price-earnings ratio.

History and utilization of revenue

Revenue has long been considered one of the most important financial indicators. It was used in the 19th century as one of the first financial indicators to measure a company's economic activity. Since then, revenue has been regularly used to evaluate companies.

Revenue is usually calculated as a percentage of the company's equity. It can also be used to determine the overall profitability of a company. There are many different types of revenue that can be used to measure a company's economic activity, such as gross revenue, net revenue, and revenue from international business.

The revenue can also be used to evaluate stocks. For example, the revenue of a company can be used to evaluate the success of the company. If a company has high revenue, it means that it is a profitable company because it has high demand for its products or services.

Calculation and Application of Revenue

In order to calculate a company's revenue, the company's income must be deducted from its expenses. The income can come from various sources, such as sales, licensing fees, services, etc. The expenses can include costs for production, procurement, inventory, sales, and administration.

The revenue can then be used to calculate various financial ratios. For example, the revenue can be used to calculate the price-earnings ratio (P/E ratio) of a company. This is a measure of a company's profitability, calculated by taking the ratio of the stock price to earnings per share.

Revenue can also be used to calculate earnings per share (EPS) of a company. This is a measure of a company's profit per share. EPS is calculated by dividing earnings by the number of shares issued.

Use of revenue by investors

Investors use revenue to evaluate stocks, as revenue is an indicator of a company's success. For example, an investor can compare a company's revenue to see how successful it is. An investor can also use a company's revenue to calculate its price-to-earnings ratio and earnings per share.

An example: An investor looks at a company that has a revenue of 25 million euros. He compares this revenue to that of the competitor, which has a revenue of 35 million euros. The investor can then see that the company with 25 million euros in revenue is less successful than the company with 35 million euros in revenue.

Advantages and Disadvantages of Revenue.

Revenue is a very useful tool for valuing stocks as it measures a company's economic activity. Revenue can also be used to calculate other financial ratios such as the price-earnings ratio and earnings per share.

However, one disadvantage is that revenue alone is not a meaningful indicator of a company's success. It is important to consider revenue in comparison to other financial metrics such as earnings per share and price-to-earnings ratio to get a complete picture of the company.

Income Statement — Mediclin

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

All Key Metrics — Mediclin